Andlauer Healthcare Group Inc. (TSE:AND – Get Rating) Director Ronald Martin Skelton sold 500 shares of the company’s stock in a transaction dated Tuesday, May 23rd. The stock was sold at an average price of C$48.66, for a total value of C$24,330.00.
Ronald Martin Skelton also recently made the following trade(s):
- On Thursday, May 18th, Ronald Martin Skelton sold 5,000 shares of Andlauer Healthcare Group stock. The stock was sold at an average price of C$48.41, for a total value of C$242,049.00.
Andlauer Healthcare Group Trading Down 1.6 %
Shares of TSE AND opened at C$45.00 on Monday. The company has a quick ratio of 1.66, a current ratio of 2.23 and a debt-to-equity ratio of 35.03. The business has a fifty day simple moving average of C$49.05 and a two hundred day simple moving average of C$48.53. The firm has a market cap of C$903.15 million, a PE ratio of 25.14 and a beta of 0.64. Andlauer Healthcare Group Inc. has a twelve month low of C$37.57 and a twelve month high of C$55.97.
Andlauer Healthcare Group (TSE:AND – Get Rating) last issued its earnings results on Wednesday, May 3rd. The company reported C$0.39 earnings per share for the quarter, missing analysts’ consensus estimates of C$0.42 by C($0.03). The firm had revenue of C$164.77 million for the quarter, compared to the consensus estimate of C$156.35 million. Andlauer Healthcare Group has a net margin of 11.48% and a return on equity of 18.50%. Analysts expect that Andlauer Healthcare Group Inc. will post 1.7864232 earnings per share for the current fiscal year.
Andlauer Healthcare Group Increases Dividends
The business also recently declared a quarterly dividend, which was paid on Monday, April 17th. Stockholders of record on Friday, March 31st were given a $0.08 dividend. This represents a $0.32 annualized dividend and a dividend yield of 0.71%. This is a positive change from Andlauer Healthcare Group’s previous quarterly dividend of $0.07. The ex-dividend date was Thursday, March 30th. Andlauer Healthcare Group’s payout ratio is presently 17.88%.
Wall Street Analyst Weigh In
AND has been the subject of a number of recent analyst reports. TD Securities upped their price objective on Andlauer Healthcare Group from C$57.00 to C$58.00 and gave the stock a “hold” rating in a research note on Monday, March 6th. Scotiabank dropped their price target on Andlauer Healthcare Group from C$55.00 to C$52.00 in a research note on Monday, May 8th. CIBC dropped their price target on Andlauer Healthcare Group from C$54.00 to C$50.00 in a research note on Friday, May 5th. Royal Bank of Canada dropped their price target on Andlauer Healthcare Group from C$53.00 to C$51.00 and set a “sector performing” rating for the company in a research note on Friday, May 5th. Finally, National Bankshares dropped their price target on Andlauer Healthcare Group from C$60.00 to C$58.75 and set an “outperform” rating for the company in a research note on Friday, May 5th. Three equity research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of C$56.68.
About Andlauer Healthcare Group
(Get Rating)
Andlauer Healthcare Group Inc, a supply chain management company, provides a platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector in Canada and the United States. The company operates in two segments, Specialized Transportation and Healthcare Logistics.
Recommended Stories
Receive News & Ratings for Andlauer Healthcare Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Andlauer Healthcare Group and related companies with MarketBeat.com’s FREE daily email newsletter.